WPCS International Incorporated (NASDAQ: WPCS) announced financial results for the fiscal year 2013 first quarter ended July 31, 2012 on Friday, September 14th, after market hours. Highlights: EBITDA of approximately $695,000 compared to an EBITDA loss of $7.1 million in preceding quarter ended April 30, 2012. Net income of approximately $994,000 or $0.14 per diluted […]
Anthera Pharmaceuticals (ANTH) shares plunged around 70% after company’s report of the mixed results for its Phase 2b PEARL-SC clinical study in patients with systemic lupus erythematosus. Paul F. Truex, Anthera’s President and Chief Executive Officer, commented: [quote style=”1″]The extensive data in the target severe population from our Phase 2 clinical program supports the initiation […]
Dynavax Technologies Corp. (DVAX) shares fell more than 20 percent yesterday after the company announced a stock offering of 17.5 million shares at $4.25/share. Also Dynavax said that its CEO, Dino Dina, was leaving the company. Dr. Dina is a “biotech” guy. He did a great work by getting the company to where it is […]
Stereotaxis, Inc. (NASDAQ:STXS) today announced the completion of the first 50 clinical procedures using the Company’s new Niobe ES system to treat patients with a variety of complex cardiac arrhythmias. A majority of the first 50 cases were performed to treat atrial fibrillation (AF), the most common type of cardiac arrhythmia. Positive initial results with […]
Endocyte Inc (NASD: ECYT) lost over 60% of its market capitalization after announcement that its cancer drug candidate was shown not to increase survival in a subset of ovarian cancer patients during a phase 2 clinical trial. ECYT stock dropped below $4 following this news on December 14th and slowly declined all week long. Done […]
We alerted Arrowhead Research (ARWR) to our Twitter followers on the pre-market news from the company: Arrowhead Research Corporation (NASDAQ: ARWR) today announced the publication of data from Ablaris Therapeutics, Inc.’s lead drug candidate, Adipotide™, demonstrating weight loss and reduction in body mass index and abdominal circumference in obese rhesus monkeys. The findings reveal a […]
Information Services Group, Inc. (ISG) (Nasdaq:III) today announced financial results for the third quarter of 2011. Highlights: Total revenues of $48.9 million, an increase of 52% from $32.2 million in the third quarter of 2010. Operating income of $1.8 million for the third quarter of 2011, including $0.6 million in restructuring costs, compared to a […]
USA Technologies, Inc. (NASDAQ:USAT) today issued the additional information regarding the resignation of Chairman and CEO George Jensen on October 14, 2011. A bit of history: Late last month, the Audit Committee of the Company’s Board of Directors was contacted with information suggesting that Mr. Jensen had been posting information about the Company on yahoo […]
Cyclacel Pharmaceuticals, Inc. (Nasdaq: CYCC) today announced that the independent Data Safety Monitoring Board (DSMB) of SEAMLESS, recommended that the Phase 3, randomized, registration-directed study of sapacitabine in elderly patients with acute myeloid leukemia (AML) should enter the randomized stage as planned. Judy H. Chiao , M.D., Vice President, Clinical Development and Regulatory Affairs of […]
Zoom Technologies, Inc. (Nasdaq: ZOOM) announced today that it it has signed a definitive agreement to acquire a 55% share of Portables Unlimited LLC (“Portables”), one of the largest exclusive wholesale distributors of T-Mobile products in the United States . Upon closing of the acquisition, ZOOM will establish its international headquarters in Portables’ offices at […]
